2016 annual financial data

XTL Biopharmaceuticals Ltd. 2016 Operating margin

XTL Biopharmaceuticals Ltd. 2016 operating margin with verified reported values.

Direct answer

Operating margin was -11,134.78%.

Operating income was -2,561,000 USD and net income was -2,545,000 USD.
Operating cash flow was -1,732,000 USD.

Get free XTL Biopharmaceuticals Ltd. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
23,000 USD
Operating income
-2,561,000 USD
Net income
-2,545,000 USD
Operating cash flow
-1,732,000 USD